Honeywell Solstice N40 Adopted by Sinopharm for Vaccine Cold Storage

Honeywell announced that Sinopharm Shanghai Biomedical, a subsidiary of China National Pharmaceutical Group (Sinopharm), has adopted Honeywell Solstice N40 (R448A) refrigerant. The energy efficient, low-global warming potential (GWP) solution will be used for cold storage of Sinopharm vaccines used in Shanghai, including the company’s COVID-19 vaccine.